Related Experiment Video

Updated: May 11, 2026

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study

Karoline Krause1, Aos Mahamed2, Karsten Weller2

  • 1Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany; Autoinflammation Reference Center Charité, Charité - Universitätsmedizin, Berlin, Germany.

The Journal of Allergy and Clinical Immunology
|May 29, 2013
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos